果皮的提升价值:对心血管疾病和糖尿病管理的影响
Bhanu Marwaha1, Supriya Singh Gaur2
1Department of Food Technology and Nutrition, Lovely Professional University, Phagwara, Jalandhar, Punjab, 144411, India.
Inflammopharmacology
|December 18, 2025
概括
果皮含有丰富的生物活性化合物,具有抗糖尿病和心脏保护作用. 本综述探讨了它们通过减少氧化应激和炎症来对抗心脏代谢疾病的潜力.
科学领域:
- 农业工业废弃物的价值化
- 营养药品和功能性食品.
- 植物化学和药理学.
背景情况:
- 果皮是丰富的农业工业副产品,来自鲁塔家族.
- 它们含有有价值的生物活性化合物,如黄酸,酸和精油.
- 这些皮肤具有重要的营养和治疗性质.
研究的目的:
- 审查果皮的营养和生物活性成分.
- 检查其抗糖尿病和心脏保护作用背后的机制.
- 突出果皮作为管理心脏代谢疾病的可持续资源.
主要方法:
- 文献综述侧重于体外和体外研究.
- 对生物活性化合物的绿色提取技术的分析.
- 研究对脂质谱和肠道微生物群的协同效应和监管影响.
主要成果:
- 果皮的化合物表现出强大的抗氧化剂,抗炎症,抗糖尿病和抗高脂作用.
- 机制包括中和反应性氧物种和抑制炎症性细胞因子.
- 观察到血糖,血压,脂质代谢和肠道微生物群的积极调节.
结论:
- 果皮是一种可持续和经济的植物成分来源.
- 它们的生物活性化合物为缓解糖尿病和心血管疾病等心脏代谢疾病提供了有希望的天然替代品.
- 需要进一步研究以体外和体外证据为重点,以充分阐明它们的治疗潜力.
相关概念视频
Atherosclerosis III: Management
290
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
290
Diabetes: Management and Pharmacotherapy
835
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
835
Coronary Artery Disease IV: Preventive Measures
563
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
563
Pathophysiology of Diabetes
3.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K
Peripheral Artery Disease III: Interprofessional Care
215
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
215
Heart Failure V: Medical Management
195
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
195


